Disease-Management of Low- and Intermediate-1 Risk Myelodysplastic Syndromes: Report on 800 Newly Diagnosed MDS Patients From the European LeukemiaNet MDS Registry

被引：0
|
作者：
de Swart, Louise [1 ]
Smith, Alex [2 ]
Fenaux, Pierre [3 ]
Symeonidis, Argyris [4 ]
Hellstrom-Lindberg, Eva [5 ]
Sanz, Guillermo [6 ]
Cermak, Jaroslav [7 ]
Georgescu, Otilia [8 ]
Germing, Ulrich [9 ]
MacKenzie, Marius [1 ]
Beyne-Rauzy, Odile [10 ]
Malcovati, Luca [11 ]
Stauder, Reinhard [12 ]
Droste, Jackie [1 ]
Bowen, David [13 ]
de Witte, Theo [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[2] Univ York, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England
[3] Hop Avicenne, Serv Hematol Clin, F-93009 Bobigny, France
[4] Greek Myeloma Study Grp, Athens, Greece
[5] Karolinska Inst, Dept Med, Div Hem, Stockholm, Sweden
[6] Hosp Univ La Fe, Dept Hematol, Valencia, Spain
[7] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[8] Fundeni Clin Inst, Bucharest, Romania
[9] Univ Klin Dusseldorf, Dusseldorf, Germany
[10] GFM, Bobigny, France
[11] Univ Pavia, Carattere Sci Policlin San Matteo, Fdn Ist Ricovero & Cura, I-27100 Pavia, Italy
[12] Innsbruck Med Univ, Dep Internal Med Haematol & Oncol 5, Innsbruck, Austria
[13] Leeds Teaching Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1201 / 1202
页数：2
相关论文
共 50 条
  • [1] Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry
    De Swart, Louise
    Smith, Alex
    Fenaux, Pierre
    Bowen, David
    Sanz, Guillermo
    Hellstrom-Lindberg, Eva
    Symeonidis, Argyris
    Cermak, Jaroslav
    Germing, Ulrich
    Stauder, Reinhard
    Georgescu, Otilia
    MacKenzie, Marius
    Malcovati, Luca
    Holm, Mette Skov
    Park, Sophie
    Beyne-Rauzy, Odile
    Droste, Jackie
    de Witte, Theo
    [J]. BLOOD, 2011, 118 (21) : 1195 - 1196
  • [2] Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry
    de Swart, Louise
    Smith, Alex
    Johnston, Tom
    Haase, Detlef
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argiris
    Sanz, Guillermo
    Hellstroem-Lindberg, Eva
    Cermak, Jaroslav
    Germing, Ulrich
    Stauder, Reinhard
    Georgescu, Otilia
    MacKenzie, Marius
    Malcovati, Luca
    Holm, Mette Skov
    Almeida, Antonio Medina
    Madry, Krzysztof
    Slama, Borhane
    Guerci-Bresler, Agnes
    Sanhes, Laurence
    Beyne-Rauzy, Odile
    Luno, Elisa
    Bowen, David
    de Witte, Theo
    [J]. BLOOD, 2013, 122 (21)
  • [3] Health-Related Quality of Life In Newly Diagnosed Low Risk and Intermediate-1 Risk MDS: Report on the First 683 Patients From the European LeukemiaNet Registry.
    Stauder, Reinhard
    Smith, Alex
    de Witte, Theo
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argyris
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo F.
    Cermak, Jaroslav
    Georgescu, Otilia
    Germing, Ulrich
    MacKenzie, Marius
    Beyne-Rauzy, Odile
    Malcovati, Luca
    Bowen, David
    [J]. BLOOD, 2010, 116 (21) : 1630 - 1630
  • [4] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Schnell, R.
    Lerchenmueller, C.
    Sauer, A.
    Severin, K.
    Germing, U.
    Steinmetz, H. T.
    [J]. ONKOLOGIE, 2012, 35 : 148 - 148
  • [5] TRANSFUSIONS AND PRESENCE OF RINGSIDEROBLASTS INFLUENCE HEPCIDIN AND NTBI LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT FROM THE EUROPEAN LEUKEMIANET MDS REGISTRY
    de Swart, L.
    Reiniers, C.
    Bagguley, T.
    Van Marrewijk, C.
    Bowen, D.
    Cermak, J.
    Hellstrom-Lindberg, E.
    Tatic, A.
    Symeonidis, A.
    Huls, G.
    Panagiotidis, P.
    Garelius, H.
    Culligan, D.
    Krejci, M.
    Droste, J.
    Smith, A.
    Swinkels, D.
    de Witte, T.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S106 - S107
  • [6] European Registry for Low Risk and Intermediate-1 Risk MDS: Base Line Report On First 400 Registered Patients
    de Witte, T. M.
    Smith, Alex
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argyris
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo
    Cermak, Jaroslav
    Georgescu, Otilia
    Germing, Ulrich
    MacKenzie, Marius
    Stander, Reinhard
    Rauzy, Odile Beyne
    Bowen, David T.
    [J]. BLOOD, 2009, 114 (22) : 1466 - 1467
  • [7] The Population-Based 'real world' of Low Risk Myelodysplastic Syndromes; Second Interim Analysis of the European LeukemiaNet MDS Registry at 800 Registered New Patients
    Bowen, David
    Smith, Alex
    Droste, Jackie
    Fenaux, Pierre
    Symeonidis, Argyris
    Hellstrom-Lindberg, Eva
    Sanz, Guillermo F.
    Cermak, Jaroslav
    Georgescu, Otilia
    Germing, Ulrich
    MacKenzie, Marius
    Stauder, Reinhard
    Beyne-Rauzy, Odile
    Malcovati, Luca
    de Witte, Theo
    [J]. BLOOD, 2010, 116 (21) : 778 - 778
  • [8] Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry
    Madry, Krzysztof
    Lis, Karol
    Fenaux, Pierre
    Bowen, David
    Symeonidis, Argiris
    Mittelman, Moshe
    Stauder, Reinhard
    Cermak, Jaroslav
    Sanz, Guillermo
    Hellstrom-Lindberg, Eva
    Langemeijer, Saskia
    Malcovati, Luca
    Germing, Ulrich
    Holm, Mette Skov
    Guerci-Bresler, Agnes
    Culligan, Dominic
    Sanhes, Laurence
    Kotsianidis, Ioannis
    van Marrewijk, Corine
    Crouch, Simon
    de Witte, Theo
    Smith, Alex
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (04) : 451 - 461
  • [9] Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry
    De Swart, Louise
    Reiniers, Chloe
    Bagguley, Tim
    Bowen, David
    Cermak, Jaroslav
    Hellstrom-Lindberg, Eva
    Tatic, Aurelia
    Symeonidis, Argiris
    Huls, Gerwin
    Panagiotidis, Panagiotis
    Garelius, Hege
    Culligan, Dominic
    Krejci, Marta
    van Marrewijk, Corine
    Droste, Jackie
    Smith, Alexandra
    Swinkels, Dorine W.
    de Witte, Theo
    [J]. BLOOD, 2015, 126 (23)
  • [10] PROGNOSTIC IMPACT OF TRANSFUSION INTENSITY ON SURVIVAL AND THROMBOCYTOPENIA IN NEWLY DIAGNOSED LOWER-RISK MDS PATIENTS PARTICIPATING IN THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGISTRY
    de Swart, L.
    Johnston, W. T.
    Smith, A.
    Fenaux, P.
    Symeonidis, A.
    Cermak, J.
    Hellstrom-Lindberg, E.
    Sanz, G.
    Stauder, R.
    Malcovati, L.
    Germing, U.
    Huls, G.
    Holm, M. S.
    Mittelman, M.
    Madry, K.
    Tatic, A.
    Almeida, A. M.
    Savic, A.
    Park, S.
    Beyne-Rouzy, O.
    Itzykson, R.
    Droste, J.
    Bowen, D.
    de Witte, T.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S23 - S24
12345